Costs of Extrapulmonary Nontuberculous Mycobacteria Disease, Denmark, 2005–2017
Victor Naestholt Dahl, Andreas Arnholdt Pedersen, Michael Høffding Ibsen, Ole Hilberg, Anders Løkke, Andreas Fløe
TL;DR
This study estimates the economic and social costs of extrapulmonary nontuberculous mycobacteria disease in Denmark from 2005 to 2017.
Contribution
The study quantifies the socioeconomic burden of ENTM disease, including healthcare costs and employment impacts.
Findings
ENTM disease was linked to higher healthcare costs.
Patients experienced reduced employment income and increased public benefits.
The disease imposes a significant socioeconomic burden.
Abstract
We estimated the direct and indirect costs associated with extrapulmonary nontuberculous mycobacteria (ENTM) disease in Denmark during 2005–2017. ENTM disease was associated with substantially higher healthcare costs, lower employment income, and increased public benefits before, around, and after diagnosis. Our findings highlight the substantial socioeconomic burden associated with ENTM disease.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1
Figure 2Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsMycobacterium research and diagnosis · Tuberculosis Research and Epidemiology · Diagnosis and treatment of tuberculosis